Clinical Trials · NCT05227196
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 546
- Start date
- Feb 2022
- Locations
- 3 sites, United States, Canada
- Primary endpoint
- AUC0-24h,semaglutide,SS Area under the semaglutide plasma concentration-time curve during a dosing interval at steady state (SS)